The tumorigenic effect of FOXM1 is also driven by other abnormalities frequently found in cancers, such as mutation of important tumor suppressors like Rb and p53, which normally inhibit FOXM1 expression and activity [51]. This evidence concerns the gene TP53 and cancer.